July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Identification and Management of Non-Diabetic Eye Disease within the National Diabetic RetinaScreen Programme
Author Affiliations & Notes
  • Brian Woods
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
  • Rory Murphy
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
  • Nihad Elseed
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
  • Loura Landi
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
  • Rajiv Pandey
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
  • David J Keegan
    Mater Retinal Research Group, Mater Misericordiae University Hospital, Dublin, Ireland
    Diabetic RetinaScreen, National Screening Service, Kings Inn House, Parnell St, Dublin, Ireland
  • Footnotes
    Commercial Relationships   Brian Woods, None; Rory Murphy, None; Nihad Elseed, None; Loura Landi, None; Rajiv Pandey, None; David Keegan, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1568. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brian Woods, Rory Murphy, Nihad Elseed, Loura Landi, Rajiv Pandey, David J Keegan; Identification and Management of Non-Diabetic Eye Disease within the National Diabetic RetinaScreen Programme. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1568.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Irish Diabetic RetinaScreen Service offers Nationwide screening to all diabetics over the age of 12. It is internationally unique given the integrated nature of its screening and treatment arms. It is now well established, demonstrating good uptake with considerable clinical impact. The aim of this study is to explore the significant number of referrals from the Diabetic RetinaScreen Service with pre-specified non-diabetic eye disease

Methods : We retrospectively examined a 12-month referral assessment database from the Mater Misericordiae University Hospital (MMUH) Diabetic Retinal Treatment (DRT) Centre from January 2016 to 2017. We established a patient cohort, which was followed until January 2018. Non-diabetic eye disease referrals were identified and analysed with respect to their frequency of referral and outcome. Patient pathways for the subsequent 12 months were examined.

Results : 1993 patients were seen in MMUH DRT during the 12-month period included in the study. Diabetic eye disease referrals comprised 1250/1,993 (63%) referrals, with 743/1,993 (37%) referred for assessment of non-diabetic eye disease. Substantial pathology sub-groups included retinal artery and vein occlusions; Arterial emboli; Cataract; Glaucoma; Age Related Macular Degeneration; and Pigmented retinal lesions. We discuss the relative contribution from each pathology, the subsequent assessment outcomes, and the subsequent 12-month patient pathways.

Conclusions : Several non-diabetic ocular pathologies, which are often asymptomatic in their early course, are being identified and referred for appropriate treatment. The referral volume is substantial, as is the subsequent referral burden on ophthalmic services. Quantifying this promotes a more informed discussion on increased service demands, helping predict its practical and financial impact, and influencing strategies on future service provisions.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×